Tower Research Capital (TRC)’s Neurotrope, Inc. Common NTRP Stock Holding History

Tower Research Capital (TRC)’s Portfolio NTRP Stock Details NTRP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-5,769	Closed	-$6K	–	5605
2020 Q3	$6K	Sell	5,769 -11,856	-67%	-$13.6K	﹤0.01%	4328
2020 Q2	$21K	Buy	+17,625	New	+$22.1K	﹤0.01%	3666
2019 Q3	–	Sell	-1,603	Closed	-$13K	–	4759
2019 Q2	$13K	Sell	1,603 -2,799	-64%	-$18.8K	﹤0.01%	2434
2019 Q1	$24K	Buy	4,402 +3,786	+615%	+$16.3K	﹤0.01%	2180
2018 Q4	$2K	Buy	+616	New	+$3.73K	﹤0.01%	3500

Other funds holding NTRP

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Tower Research Capital (TRC)'s NTRP Position: Q4 2020 in Review

Tower Research Capital (TRC) sold out of Neurotrope, Inc. Common (NTRP) in Q4 2020, closing a stake of 5,769 shares — an estimated $6K sold.

Tower Research Capital (TRC) first reported a position in NTRP in Q4 2018 and held it in 5 quarters. The position peaked at $24K in Q1 2019. 1 fund tracked by Wall St. Rank holds NTRP as of Q4 2020.

Tower Research Capital (TRC) reported no remaining Neurotrope, Inc. Common position as of Q4 2020 after selling out during the quarter.
Tower Research Capital (TRC) sold 5,769 Neurotrope, Inc. Common shares in Q4 2020, an estimated $6K.
Tower Research Capital (TRC) first reported a position in Neurotrope, Inc. Common in Q4 2018 and held it in 5 quarters.
Tower Research Capital (TRC)'s Neurotrope, Inc. Common position peaked at $24K in Q1 2019.
1 fund tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q4 2020.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2020, filed 16 Feb 2021.